Abstract
In contrast to protein kinases that participate in long-term potentiation (LTP) induction and memory consolidation, the autonomously active atypical protein kinase C isoform, protein kinase Mzeta (PKMζ), functions in the core molecular mechanism of LTP maintenance and long-term memory storage. Here, using multiple complementary techniques for light and electron microscopic immunolocalization, we present the first detailed characterization of the cellular and subcellular distribution of PKMζ in rat hippocampus and neocortex. We find that PKMζ is widely expressed in forebrain with prominent immunostaining in hippocampal and neocortical grey matter, and weak label in white matter. In hippocampal and cortical pyramidal cells, PKMζ expression is predominantly somatodendritic, and electron microscopy highlights the kinase at postsynaptic densities and in clusters within spines. In addition, nuclear label and striking punctate immunopositive structures in a paranuclear and dendritic distribution are seen by confocal microscopy, occasionally at dendritic bifurcations. PKMζ immunoreactive granules are observed by electron microscopy in cell bodies and dendrites, including endoplasmic reticulum. The widespread distribution of PKMζ in nuclei, nucleoli and endoplasmic reticulum suggests potential roles of this kinase in cell-wide mechanisms involving gene expression, biogenesis of ribosomes and new protein synthesis. The localization of PKMζ within postsynaptic densities and spines suggests sites where the kinase stores information during LTP maintenance and long-term memory.
Keywords: long-term potentiation, PKMzeta, electron microscopy
1. Introduction
The ability of protein kinase Mzeta (PKMζ) to maintain long-term potentiation (LTP) and memory is due to its unique structure as an autonomously active protein kinase C (PKC) isoform [1,2]. Full-length PKC isoforms consist of an N-terminal regulatory domain and a C-terminal catalytic domain. Under basal conditions in the cell, the regulatory domain maintains inhibition of the catalytic domain. Second messengers bind to the regulatory domain and induce a temporary conformational change in the enzyme that releases this autoinhibition. Thus, most PKC isoforms, like many other protein kinases and signalling molecules, participate transiently in signal transduction and in the initial induction of LTP.
Protein kinase Mzeta (PKMζ), by contrast, consists of an independent PKCζ catalytic domain, which, lacking the autoinhibition of the ζ regulatory domain, is autonomously and thus persistently active. PKMζ is generated by an internal promoter within the ζ gene that produces a PKMζ mRNA encoding an independent ζ catalytic domain [3] which is transported to the dendrites of neurons [4]. PKMζ mRNA and protein are expressed almost exclusively in brain, whereas the full-length PKCζ mRNA and protein are not expressed in forebrain, except in the lateral olfactory tract [3,5,6]. Therefore, in hippocampus and neocortex, immunostaining with antisera to ζ will specifically determine the localization of PKMζ.
PKMζ protein persistently increases during LTP, and this increase correlates with the extent and duration of synaptic potentiation during LTP maintenance [7]. The persistent activity of PKMζ is both necessary and sufficient for maintaining synaptic LTP [8] and long-term memory storage [9,10]. In addition, during the protein synthesis-dependent, late form of LTP in the hippocampus, PKMζ plays a role in the initial upregulation of new protein synthesis, including increased synthesis of PKMζ itself, which is crucial for the transition from early- to late-LTP [11,12]. Following the de novo synthesis of PKMζ [3], the autonomous activity of the kinase maintains synaptic potentiation for hours to days [8,9,13,14]. Similarly, after learning, the persistent activity of PKMζ maintains many forms of long-term memory, including spatial [9] and trace conditioning [13] in the hippocampus and elementary associations [10,15–17], extinction [18] and skilled sensorimotor memories [19] in the neocortex. Persistent PKMζ activity maintains long-term memory from 1 day to up to three months, the longest time point examined [15]. Because the half-life of PKMζ may be shorter than the duration of the memories that it maintains, positive feedback of protein synthesis has been proposed to sustain appropriate levels of the kinase [2,12,20]. Thus, in addition to its role in maintaining increases in synaptic potentiation, PKMζ may participate in a sustained upregulation of gene expression.
PKMζ also has been reported to contribute to metaplasticity [13,21,22] and neuroprotection [23], functions that may be localized, in part, outside the synapse. In addition, PKMζ has been implicated in several disease states that may be related to pathophysiological alterations of its normal synaptic or extrasynaptic functions, including chronic neuropathic pain [24,25], post-traumatic stress disorder [26] and Alzheimer's disease [27].
To gain insight into the mechanisms by which PKMζ may maintain changes in synaptic and extrasynaptic neuronal function, we examined the cellular and subcellular distribution of the kinase, focusing on rat neocortex and hippocampus, sites where PKMζ functions to store long-term memory. Using complementary immunohistochemical approaches at the light microscopic and ultrastructural level, we demonstrate wide distribution of the enzyme that not only highlights the expected postsynaptic localization of PKMζ, but also nuclear, nucleoli and extrasynaptic dendritic label within neurons. These findings suggest multiple, distributed sites of PKMζ-mediated information storage in neurons.
2. Material and methods
(a). Antibodies
The production and characterization of antiserum recognizing a specific sequence (TLPPFQPQITDDYGL) within the catalytic domain of PKCζ and PKMζ have been described previously [3]. Absence of immunostaining was confirmed in PKMζ knock-out mice (data not shown).
(b). Anaesthesia
Male two to three month-old Sprague–Dawley rats were anaesthetized by intraperitoneal injection with sodium pentobarbital (45 mg/60 g body weight, Anpro Pharmaceutical, Arcadia, CA, USA) before intracardiac perfusion, according to State University of New York Downstate Medical Center Animal Use and Care Committee standards. All efforts were made to minimize animal suffering and to reduce the number of animals used.
(c). Perfusion and fixation
Figure 1. For panels a–i, the animals were perfused through the aorta for 3 min with 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS), pH 7.4. The brains were removed and postfixed overnight in 4% PFA in PBS, pH 7.4 and transferred to 30% sucrose in PBS until the brains were isopycnic with the solution. The brains were quickly frozen in n-methyl-butane, cooled over dry ice, and kept at −70°C for cryostat sectioning. For panels j and k, after anaesthesia, brains were postfixed in 10% neutral-buffered formalin overnight and embedded in paraffin, as previously described [6].
Figure 1.
PKMζ immunohistochemisty by light microscopy. PKMζ is widely expressed in brain with predominant label in grey matter but only weak label in white matter. Hippocampus: (a–e) the most prominent immunopositivity occurs in the pyramidal cell layer (a–d, *), especially in CA1 (c), CA3 (d), and the granular cell layer of the dentate gyrus (a,b,e, **). By contrast, the alveus (a) shows little to no immunoreactivity (a–c). Cerebellum: (f,g) PKMζ immunoreactivity is most striking in the molecular layer (m), less prominent in the granular cell layer (gr), and virtually absent in the cerebellar white matter (w). Purkinje cell immunolabel (p, arrowheads) is often intense but varies from area to area. (g) Higher magnification of the cerebellum displays label of cells within the molecular (m) and Purkinje cell (p, arrowhead) layers, many in an intranuclear distribution. Negative controls: (h) Section following pretreatment of antibody with antigen and (i) section treated in the absence of primary antibody show no significant immunolabel. Neocortex: (j,k) PKMζ is widely expressed in neurons, mainly in a somatodendritic distribution (k). Nuclear label is more variable (k), ranging from absent (small black arrowhead) to diffuse (large black arrowhead). In addition, occasional neurons display dot-like structures within the nucleus (large white arrowhead) or in a paranuclear location (small white arrowhead). ctx, cortex; th, thalamus; a, alveus; o, stratum oriens; *, stratum pyramidale; r, stratum radiatum; lm, stratum lacunosum-moleculare; **, stratum granulosum of the dentate gyrus; ml, stratum moleculare of the dentate gyrus; CA1, cornu ammonis 1; CA3, cornu ammonis 3; DG, dentate gyrus; CRBL, cerebellum; gr, granular layer of the cerebellum; p, Purkinje cell layer; m, molecular layer of the cerebellum; w, white matter. Black bar: (a,h,i) 1 mm; (b,f) 500 μm; (c–e,g) 100 μm; white bar: (j) 200 μm; (k) 40 μm.
Figure 2. The animals were perfused through the aorta for 3 min with 4% PFA in PBS, pH 7.4, and the brains were postfixed overnight in the same buffer at 4°C.
Figure 2.
PKMζ immunohistochemistry by confocal microscopy. (a,b) Immunofluorescence of PKMζ label in the hippocampal formation of rat brain. Strong immunostaining is observed in neurons in the pyramidal cell layer (p) of cornu ammonis and the granular cell layer of the dentate (g). Moderate label is observed in stratum lacunosum-moleculare (lm) of CA1 and CA3, the molecular cell layer of the dentate (ml), and the stratum oriens (o) and radiatum (r) of CA1 and CA3. (c) At higher magnification of CA1, brightly labelled punctate structures are observed within the cell bodies of pyramidal neurons, often in a paranuclear distribution, as well as within their dendritic projections (arrowheads) in the stratum radiatum. (d) Control tissue treated without primary antibody does not demonstrate any immunofluorescence. Scale bars: (a) 500 μm, (b) 200 μm, (c,d) 33.3 μm.
Figures 3–5; electronic supplementary material, figure S1. For pre- and post-embedding immuno-electron microscopy, the animals were perfused through the aorta for 3 min with 4% PFA with 0.2% glutaraldehyde in PBS pH 7.4. The brains were then transferred to fresh fixative for 24–40 h.
Figure 3.
Postsynaptic distribution of PKMζ in pyramidal neurons of the hippocampus. (a–d) Pre-embedding immuno-electron microscopy for PKMζ detected by DAB staining. PKMζ label is predominantly postsynaptic but varies from striking involvement of the PSD (a–d, small black arrowheads) to absent (a, small white arrowhead). Occasionally, the immunoreactivity extends beyond the PSD to involve the entire spine (b,d, large black arrowheads). By contrast, presynaptic terminals (b,c, large white arrowheads) are immunonegative. (e–h) Post-embedding immuno-electron microscopy for PKMζ detected by immunogold. PKMζ is in spines near or associated with the postsynaptic density (e,f,h, small black arrowheads). (f) Oblique view of PSD shows abundant PKMζ immunostaining. PKMζ is also observed in clusters within spines (e,g,h, large black arrowheads). Scale bars: (a) 0.55 μm, (b) 0.45 μm, (c,d) 0.53 μm, (e) 0.875 μm, (f) 0.45 μm, (g) 0.68 μm, (h) 0.50 μm.
Figure 4.
Pre-embedding immuno-electron microscopy for PKMζ. Subcellular distribution of PKMζ in pyramidal neurons of the hippocampus. (a) Light microscopic examination of 1 μm thick plastic sections treated with PKMζ antibody reveals striking somatodendritic label (small arrowheads) of CA1 neurons. Some of these cells also display variable label within their nuclei (large arrowhead) similar to that observed in figure 1. (b–f) Corresponding electron microscopic study of 80 nm thin sections further highlights the distribution of PKMζ immunopositivity in distinct subcellular compartments. Neurites: (b) myelinated axons reveal slight PKMζ immunopositivity in some axons (black arrowheads) and the absence of staining in others (white arrowheads). Nuclei: PKMζ immunostaining in the nucleus varies from neuron to neuron, ranging from no reaction product (c,e, large white arrowheads), to those with abundant reaction product (c,e, black arrowheads) distributed heterogeneously throughout the nucleus and abutting the nucleoli (d). An electron dense granular structure (e, small white arrowhead, and inset) is observed in a paranuclear distribution in some cells. (f) Abundant reaction product is present in irregular granular structures as well as dispersed throughout the dendritic shaft (small black arrowheads). N, nucleus; n, nucleolus; Ax, axons. Scale bars: (a) 40 μm, (b) 1.2 μm, (c,e) 16 μm, (d) 1.5 μm, (f) 1.7 μm, (e, inset) 2.0 μm.
Figure 5.

Post-embedding immuno-electron microscopy for PKMζ. Subcellular distribution of PKMζ in CA1 pyramidal neurons. Immunogold label is noted within nucleolus (n) (a, arrowhead), nucleus (N) (b, arrowhead and inset), and, close to the nuclear membrane adjacent to nuclear pores (c, arrowhead). (d–f) In the cytosol, PKMζ is observed near the endoplasmic reticulum (d, arrowhead) and in the dendritic shaft as a component of granules of various sizes (e,f, arrowheads and f, inset). N, nucleus; n, nucleolus; ER, endoplasmic reticulum. Scale bars: (a) 1 μm, (b) 1.4 μm, (c,f) 0.8 μm, (d) 0.175 μm, (e) 0.4 μm, (b, inset) 0.24 μm, (f, inset) 0.13 μm.
(d). Immunohistochemistry
Unless otherwise stated, all experiments were performed at room temperature.
Figure 1. Immunohistochemisty for PKMζ by light microscopy. For panels a–i, cryostat sections (40 µm, cryostat at −20°C) were rinsed three times for 5 min each in 10 mM phosphate buffer (PB), pH 7.4. To inhibit endogenous peroxidase, the sections were incubated for 5 min in antiperoxidase buffer (10% methanol, 3% H2O2, 80% PB, 7% H2O), followed by three washes (5 min each) in PB and two washes in PB–0.3% Triton. The sections were pre-incubated 30 min in blocker (PB–1.5% normal goat serum) and then incubated with primary antibody diluted in blocker (ζ catalytic; 1 : 100) on a shaker overnight at 4°C. Sections were washed three times (5 min each) in PB–0.3% Triton, blocked for 30 min, and incubated for 1 h in biotinylated secondary antibody (VECTASTAIN ABC Systems, Vector Laboratories, goat anti-rabbit, 1 : 500). Sections were washed three times (5 min) in PB–0.03% Triton, once (5 min) with PB–0.3% Triton, blocked for 30 min and then incubated in the ABC reagent (100 µl of solution A and 100 µl of solution B in PB–0.03% Triton; VECTASTAIN ABC Systems). Sections were washed three times (5 min) in PB–0.3% Triton, rinsed twice (5 min) in 0.05 M Tris (pH 7.6) and incubated for 5 min in diaminobenzidine (DAB) reaction (10 mg DAB in 0.05 M Tris, pH 7.5). Colour was developed by incubating the sections in DAB–1% H2O2. The reaction was stopped by rinsing slices in 0.05 M Tris (pH 7.5). Sections were washed three times (5 min) in PB and mounted with Permount solution (Fisher Scientific). For controls, sections were incubated in primary ζ-catalytic antiserum (1 : 100) pre-incubated with immunizing peptide (100 ng ml–1) for 1 h before use (h), or in blocker instead of primary diluted in blocker (i).
For panels j and k, immunohistochemistry on paraffin-embedded rat brains was performed as previously described [27]. Paraffin sections (8 µm) were deparaffinized in xylene, rehydrated through graded series of ethanol, submerged in 10 mM citrate buffer (pH 6.0) and microwaved for 5 min. Slides were then rinsed in PBS for 5 min, treated with 99% formic acid for 2 min and rinsed in PBS. Sections were treated with 3% H2O2 for 10 min, rinsed in PBS for 5 min, blocked in 4% normal goat serum for 20 min and incubated in primary antibody (1 : 200) in a humidity chamber overnight. The sections were then rinsed in two changes of PBS for 10 min, incubated in blocker for 30 min and then for 1 h in biotinylated secondary antibody (goat anti-rabbit 1 : 500, VECTASTAIN ABC Systems). Sections were rinsed in water, counter-stained with Gill's hematoxylin for 5 min, rinsed twice, dipped in blueing solution 10 times, rinsed again, dehydrated and mounted with Permount solution (Fisher Scientific). For controls, sections were treated as mentioned above with omission of primary antisera (1 : 200) or with antisera preimmune serum (1 : 200) (data not shown).
Figure 2. Immunohistochemistry for PKMζ by confocal microscopy. Vibratome brain sections (40 µm) were rinsed three times (5 min) in PBS, pH 7.4, transferred to 20% DMSO in PBS until the sections were isopycnic with the solution and subjected to six cycles of freezing (−20°C) and thawing [28,29] to permeabilize without detergent to mitigate compromise of ultrastructural detail. Sections were then incubated for 10 min with 0.1% glycine in PBS to quench free aldehydes, and rinsed with PBS for 10 min.
The sections were then incubated in blocking buffer (5% normal goat serum in PBS) for 1 h and then overnight in primary antibody (1 : 200) in blocking buffer (a–c), or blocking buffer alone as control (d). The sections were then rinsed in PBS, four times for 20 min each and incubated with goat anti-rabbit Alexa Fluor 488 (1 : 200) in blocking buffer overnight on a rotator at room temperature in the dark. The sections were rinsed three times in PBS, washed in distilled water and mounted on glass slides with Prolong Gold (Molecular Probes, Eugene, OR, USA).
Figures 3a–d and 4, and electronic supplementary material, figure S3b. Pre-embedding immuno-electron microscopy for PKMζ. After fixation, 50 µm vibratome sections were stored in PB with 0.02% sodium azide for up to two weeks. To inhibit endogenous peroxidase, the sections were incubated for 5 min in 3% H2O2 in PB followed by three washes, 5 min each, in PB. Sections were incubated in 0.1% glycine in PB to quench aldehydes for 30 min, rinsed in PB three times, 10 min each, permeabilized with 0.05% Triton X-100 in PB for 30 min and then rinsed as before. Sections were blocked with 5% normal goat serum, 0.1% bovine serum albumin (or 0.1% acetylated bovine serum albumin for electronic supplementary material, figure S3) and 0.1% cold-water fish gelatin in PBS for 1 h, incubated in primary antibody diluted in the blocking solution at 4°C overnight (1 : 200) and then rinsed three times with PB. For DAB, the sections were incubated 2 h with goat anti-rabbit biotinylated secondary antibodies. After rinsing with PB, the sections were incubated in streptavidin–horseradish peroxidase for 1 h, rinsed and developed in DAB solution for 12 min. For pre-embedded immunogold (see electronic supplementary material, figure S3b), after rinsing with PBS containing 0.1% acetylated bovine serum albumin and 0.1% cold-water fish gelatin (washing solution) for 2 h, the sections were incubated overnight with Alexa Fluor 488 FluoroNanogold Fab’ fragment of goat anti-rabbit IgG (1.4 nm diameter) secondary antibodies in the washing solution. Sections were then extensively rinsed (12× for 20 min each) with washing solution and then incubated in PBS overnight. The sections were fixed in 4% PFA and 0.2% glutaraldehyde for 1 h. After fixation, the sections were washed in PBS (2× 10 min each) and transferred to enhancement conditioning solution (ECS, Aurion, The Netherlands) for four washes, 15 min each. The sections were then silver intensified with silver HQ (Aurion) for 100 min and transferred to ECS containing 50 mM sodium thiosulfate for 15 min.
For both DAB and silver-intensified gold, sections were rinsed in PB and postfixed in 1% OsO4 in PB for 1 h. Sections were then dehydrated in a graded series of ethanol 50, 70, 80 and 95%, followed by three changes of 100% ethanol. Sections were then immersed in a mixture of 1 : 1 ethanol and Embed 812 resin (Electron Microscopy Sciences, Fort Washington, PA, USA) for 1 h, transferred to 100% Embed 812 and then embedded between two Aclar plastic sheets at 60°C overnight. CA1 was dissected from the hippocampus, re-embedded in a BEEM capsule and sectioned at either 1 µm, mounted on a glass slide, and counter-stained with 0.5% azure B and methylene blue (figure 4a and electronic supplementary material, figure S1a), or at 80 nm, mounted on grids, stained with 4% uranyl acetate and lead citrate [30] and examined with a Zeiss EM10c transmission electron microscope (Zeiss, Germany) (figures 3a–d and 4b–f). For controls (see electronic supplementary material, figure S1), sections were incubated in blocking solution without primary antibody.
Figures 3e–h and 5, electronic supplementary material, figure S3a. Post-embedding immuno-electron microscopy for PKMζ. Post-embedding immuno-electron microscopy was performed as previously described by Bergersen et al. [31], with few modifications. After fixation, 50 µm vibratome sections from CA1 region of rat hippocampus were collected. Pyramidal cell layer and radiatum from CA1 were dissected and cryoprotected in 30% sucrose. The samples were then placed into liquid propane and cooled to −190°C with liquid nitrogen in a Leica CPC plunge freezer (Reichert-Jung, Wien, Austria). Tissue blocks were transferred with precooled forceps to the freeze-substitution unit (Leica AFS), and immersed in a solution of anhydrous methanol and 0.5% uranyl acetate overnight at –90°C. The temperature was raised stepwise in 4°C increments per hour from −90°C to −45°C, at which temperature it was then maintained for subsequent steps. Tissue samples were washed several times with anhydrous methanol to remove residual water and uranyl acetate. Stepwise infiltration in Lowicryl HM20 (Electron Microscopy Sciences, Hatfield, PA, USA) went from Lowicryl/methanol 1 : 2, 1 : 1 and 2 : 1 (1 h each), to pure Lowicryl (overnight). For polymerization, the tissue was placed in a precooled embedding mould. The polymerization was catalysed by UV light at a wavelength of 360 nm for 2 days at −40°C, followed by 1 day at room temperature. Ultrathin sections (80 nm) were cut with a diamond knife on a Leica Ultracut E ultramicrotome and mounted on Formvar-coated nickel grids. Grids with the ultrathin sections were washed on drops of PBS for 10 min at room temperature, etched for 10 s on drops of saturated solution of sodium hydroxide and washed again in PBS. Sections were then washed for 10 min on drops of PBS containing 50 mM glycine and then on drops of 0.1% sodium borohydride/PBS and blocked for 1 h in PBS containing 4% goat serum and 2% bovine serum albumin. The sections were incubated overnight with primary antibodies (dilution 1 : 100) in blocker solution. The grids were then rinsed on drops of Tris buffer, pH 7.0, incubated for 2 h with 12 nm gold conjugated anti-rabbit Fab2 (Nanoprobes Incorporated, Stony Brook, NY, USA) in Tris (1 : 20), rinsed again with distilled water and air dried. The sections were then contrasted with a saturated solution of uranyl acetate (20–40 min), before imaging with a Zeiss EM10C electron microscope. For controls, sections were incubated in blocking solution without primary antibody; they showed few, randomly distributed gold particles (data not shown).
(e). Immunoblotting
Tissue Preparation for Immunoblotting— Eight week-old Sprague–Dawley male rats were anaesthetized with isofluorane. The tissue was rapidly dissected and washed three times in homogenization buffer at 4°C (0.32 M sucrose, 50 mM Tris–HCl (pH 7.5), 1 mM EDTA, 1 mM EGTA, 0.1 mM phenylmethanesulfonyl fluoride, 5 mM benzamidine, 17 kallikrein units ml–1 aprotinin, 0.1 mM leupeptin, 5 mM β-mercaptoethanol). The tissue was homogenized with a motorized pestle in a Teflon glass Potter–Elvehjem tissue grinder. The total homogenate was immediately heated (4 : 1 v/v) in 5× sample buffer (312.5 mM Tris–HCl (pH 6.8), 12.5% w/v SDS, 25% v/v β-mercaptoethanol, 50% glycerol) for 5 min at 95°C. For the cytoplasmic fraction, the homogenate was centrifuged at 3000g for 5 min at 4°C, and the supernatant was combined with 5× sample buffer. For the enriched nuclear fraction, the pellet was resuspended in 10 volumes of homogenization buffer and combined with 5× sample buffer.
Immunoblotting—Samples were subjected to SDS-PAGE. Total protein of 10 µg cm–1 lane from total homogenate, cytoplasmic and nuclear fractions was loaded. The SDS-PAGE was transferred to nitrocellulose and blocked for 1 h in 1% bovine serum albumin, 1% haemoglobin in 10 mM Tris–HCl, 150 mM NaCl, 0.2% Nonidet P-40. The nitrocellulose was incubated for 1 h in primary antibody (the ζ-specific antibody and poly(ADP-ribose) polymerase-1 (PARP-1) monoclonal antibody MCA 1522 (ABD Serotec, Raleigh, NC, USA; 1 : 1000 for both), and then for 1 h in secondary antibody coupled to alkaline-phosphatase (1 : 2000; Promega, Madison, WI, USA). Development was with 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium (Promega, Madison, WI, USA). The relative molecular mass for PKMζ is 52 kDa and for PARP-1 is 110 kDa.
3. Results
(a). Regional distribution of PKMζ
At low magnification, PKMζ is abundantly expressed in grey matter and weakly expressed in white matter of neocortex, hippocampus and thalamus (figure 1a). In the hippocampal formation (figures 1a–e and 2a–c), pyramidal cell bodies of CA1 and CA3, as well as granular cell bodies of the dentate show strong expression of PKMζ. Neocortex shows similar expression in pyramidal cell layers II–VI (figure 1j,k).
The cerebellum, which expresses both PKCζ and PKMζ [3,6], shows strong label in the molecular and granular layers and variable intensity of label of Purkinje cell bodies (figure 1f,g). As in forebrain, white matter displays relatively weak immunoreactivity (figure 1f,g). Controls using peptide competition and absent primary antibody show minimal staining (figures 1h,i and 2d).
(b). Synaptic and somatodendritic compartmentalization of PKMζ
Somatodendritic localization of PKMζ is striking in virtually all neocortical and hippocampal neurons (figures 1k, 2c and 3–5; electronic supplementary material, figure S2). Consistent with its proposed function to maintain potentiation in specific subsets of synapses during long-term memory storage [1,2], variation in the abundance of PKMζ immunoreactivity is observed by electron microscopy within dendritic spines of CA1 neurons (figure 3). The PKMζ immunoreactivity is often localized within and adjacent to the postsynaptic density (PSD; figure 3, small black arrowheads), and in the centre of spines (figure 3, large black arrowheads), with some spines showing heavy (figure 3a, small black arrowhead) and others light or no immunostaining (figure 3a, small white arrowhead). In addition, PKMζ immunoreactivity is observed within granular structures (figures 4e and 5e,f), as well as more diffusely throughout the dendritic shaft (figure 4f). Within the soma, PKMζ immunostaining is observed in a paranuclear distribution adjacent to the nuclear membrane (figure 2c and electronic supplementary material, figure S2), and in the region of the endoplasmic reticulum (figure 5d and electronic supplementary material, figure S3). PKMζ was rarely observed in mitochondria and was not observed in Golgi (data not shown). Axonal projections show weak or absent immunostaining (figure 4b), consistent with the sparse label observed in the white matter by light microscopy (figure 1a,b,f).
(c). Nuclear compartmentalization of PKMζ
The expression of PKMζ in the nuclei of neurons is heterogeneous, varying from strong to very weak (figures 1k and 4a,c,e). In some nuclei, PKMζ immunostaining is widely distributed (figure 4c,e); in others, immunopositivity is most prominent within nucleoli (figures 1k and 5a), surrounding the nucleolus (figure 4d) and in the region of chromatin projections (figure 5b and inset). Immunostaining is also observed near the nuclear envelope and nuclear pores (figure 5c). The presence of PKMζ in nuclei was confirmed by subcellular fractionation (see electronic supplementary material, figure S4).
(d). Granules and punctate structures
PKMζ immunoreactivity is observed within granules or aggregates of varying size by light and electron microscopy. They are seen in dendrites and cell bodies of pyramidal cells in hippocampus as well as in cortical neurons in a juxtanuclear localization. By light microscopy, punctate PKMζ-immunopositivity is noted in the cell bodies of some pyramidal cell neurons in neocortex and CA1, mainly in a paranuclear distribution, as well as within dendrites (figures 1k and 2c and electronic supplementary material, figure S2). Dot-like structures are also prominent at some dendritic bifurcations (figure 2c). The number of these paranuclear and dendritic structures varies from animal to animal (data not shown). Pre-embedding immuno-electron microscopy reveals immunopositive granules within cell bodies in a paranuclear distribution (figure 4e and inset), although these are less commonly seen than those observed by light microscopy. Smaller immunopositive granules are commonly noted within dendritic shafts by electron microscopy (figures 4f and 5e,f and f inset).
4. Discussion
Here, we present the first detailed investigation at the light and electron microscopic level of the distribution of PKMζ in brain. PKMζ is abundantly expressed in neocortex and hippocampus, consistent with previous quantitative immunoblot [6] and mRNA in situ hybridization [4,5]. PKMζ immunoreactivity is prominent in dendritic spines as well as in nuclei and other intraneuronal structures associated with gene expression. The varied abundance of PKMζ among these structures suggests that PKMζ participates dynamically in multiple cellular processes in the maintenance of synaptic plasticity and memory.
(a). Postsynaptic localization
The localization of PKMζ immunoreactivity within dendrites, dendritic spines and synapses indicates sites of PKMζ's physiological role in the maintenance of LTP and long-term memory [2]. Some synapses are heavily immunostained, whereas others appear not stained at all. This result supports the notion that long-term information is stored as the patterns of synaptic weights, with some synapses maintained in a baseline state by homeostatic processes and others maintained in a potentiated state by LTP [2]. Within spines containing the kinase, PKMζ is found in multiple locations—within the PSD, adjacent to the PSD and in clusters at the centre of the spine. This variation in intraspine location is consistent with PKMζ's proposed mechanism of synaptic potentiation by altering the dynamics of AMPA receptor trafficking into and out of the PSD through the regulation of receptor endocytosis [2,32]. Initial work with mouse knock-outs of PKMζ have questioned the role of PKMζ in synaptic plasticity and memory [33,34], reporting normal LTP and long-term memory in the constitutive PKMζ knock-out for various tasks. More recent studies, however, have found compensation in the constitutive knock-out by other PKC isoforms [35], particularly with the other atypical isozyme, PKCι/l, that mediates early-LTP expression [36]. Blocking PKMζ gene expression by either antisense oligodeoxynucleotides in wild-type rats and mice or conditional knock-out in mice prevents late-LTP and long-term memory [37]. The postsynaptic localization of PKMζ in normal animals observed in the current study further supports the function of PKMζ as an active mediator of synaptic strength. Quantification of the subcellular distribution of PKMζ in spines after LTP and memory formation will be an important area for future investigation.
Our current results are consistent with the recent quantitative electron microscopic analysis in dentate gyrus of rhesus monkeys by Hara and co-workers [38], who used an antibody recognizing atypical PKC (both ζ and ι/l isoforms), as well as a second antibody recognizing AMPA receptor subunit GluA2, whose postsynaptic trafficking is regulated by PKMζ [32,39,40]. They found that higher proportions of dendritic spines coexpressing these two molecules correlated with faster delayed non-matching-to-sample-task acquisition and more accurate recognition memory [38]. Their findings are compatible with the synaptic localization of PKMζ demonstrated here and PKMζ's role in GluA2-mediated AMPA receptor trafficking [32,39,40].
(b). Nuclei and nucleoli
The variability observed in nuclear label, from intense to undetectable, suggests that PKMζ's function in the nucleus may also be dynamically regulated, perhaps as a consequence of long-term changes in the capacity of specific networks of neurons to sustain plastic changes. In particular, the localization of PKMζ to chromatin raises the possibility that the kinase may be important for epigenetic regulation of gene expression, a process well known to regulate synaptic plasticity [41,42], initial memory consolidation [43,44], as well as memory maintenance [45]. Within nuclei, PKCζ has been reported to phosphorylate nucleolin, an important regulator of chromatin remodelling and gene expression [46,47]. Our finding that PKMζ also localizes to nucleoli (figure 5a), suggests the possibility of a role in ribosomal RNA synthesis and the processing and the biogenesis of ribosomes.
(c). Dendritic punctate structures
PKMζ immunoreactivity was seen within granules or punctate structures of varying size in dendrites and the cell body. Similar structures, observed by others in neurons have been referred to as botrysomes [48], or other terms [49], which have been described as nucleoli-like structures located in the cytoplasm that have no membrane boundaries. The function of botrysomes is not clearly established, but they may play a role in protein synthesis [50]. Botrysomes have been shown to increase with neuronal plasticity [48,51,52] and neurite outgrowth [53] and have been reported to contain AMPA receptors [54].
(d). Localization to multiple sites of gene expression and the role of PKMζ in plasticity-regulated synthesis of PKMζ
PKMζ has been proposed to regulate its own synthesis in both the induction and maintenance of LTP and long-term memory. PKMζ has been shown to regulate new protein synthesis during the induction of LTP, including, in a positive feedback loop, its own translation from PKMζ mRNA [11,12]. In addition, because PKMζ maintains neocortex-dependent memories for up to three months, if the half-life of the kinase is shorter than the duration of PKMζ-dependent memory, then increased synthesis of PKMζ might be continually required to perpetuate these very long-term memories. Thus, the distribution of PKMζ in the cell-wide, gene expression machinery may be part of an extensive positive feedback loop to maintain increased amounts of the kinase that could be available locally to synapses at levels appropriate for synaptic potentiation [2].
In conclusion, PKMζ is widely expressed in pyramidal neurons with intracellular compartmentalization in structures that mediate both gene expression and excitatory synaptic transmission. PKMζ functions in synaptic plasticity to regulate activity-dependent, new protein synthesis [11], and metaplastic [13,21,22] and neuroprotective [23] roles of PKMζ have also been reported. Although localization to a specific intracellular compartment does not indicate function within the structure, the presence of PKMζ in nucleus, nucleolus, botrysome-like structures and endoplasmic reticulum suggests the possibilities that PKMζ functions in gene expression, biogenesis of ribosomes and new protein synthesis. The variation in abundance of PKMζ at PSDs and spines supports the cognitive role of PKMζ in storing information at synapses by the molecular mechanism of LTP maintenance [2].
Funding statement
This research was supported by R37MH057068, R01MH53576 and R01DA034970 (T.C.S.).
References
- 1.Sacktor TC, Osten P, Valsamis H, Jiang X, Naik MU, Sublette E. 1993. Persistent activation of the ζ isoform of protein kinase C in the maintenance of long-term potentiation. Proc. Natl Acad. Sci. USA 90, 8342–8346 (doi:10.1073/pnas.90.18.8342) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Sacktor TC. 2011. How does PKMζ maintain long-term memory? Nat. Rev. Neurosci. 12, 9–15 (doi:10.1038/nrn2949) [DOI] [PubMed] [Google Scholar]
- 3.Hernandez AI, Blace N, Crary JF, Serrano PA, Leitges M, Libien JM, Weinstein G, Tcherapanov A, Sacktor TC. 2003. Protein kinase Mζ synthesis from a brain mRNA encoding an independent protein kinase Cζ catalytic domain. Implications for the molecular mechanism of memory. J. Biol. Chem. 278, 40 305–40 316 (doi:10.1074/jbc.M307065200) [DOI] [PubMed] [Google Scholar]
- 4.Muslimov IA, Nimmrich V, Hernandez AI, Tcherepanov A, Sacktor TC, Tiedge H. 2004. Dendritic transport and localization of protein kinase Mζ mRNA: implications for molecular memory consolidation. J. Biol. Chem. 279, 52 613–52 622 (doi:10.1074/jbc.M409240200) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Oster H, Eichele G, Leitges M. 2004. Differential expression of atypical PKCs in the adult mouse brain. Brain Res. Mol. Brain Res. 127, 79–88 (doi:10.1016/j.molbrainres.2004.05.009) [DOI] [PubMed] [Google Scholar]
- 6.Naik MU, Benedikz E, Hernandez I, Libien J, Hrabe J, Valsamis M, Dow-Edwards D, Osman M, Sacktor TC. 2000. Distribution of protein kinase Mζ and the complete protein kinase C isoform family in rat brain. J. Comp. Neurol. 426, 243–258 (doi:10.1002/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8) [DOI] [PubMed] [Google Scholar]
- 7.Osten P, Valsamis L, Harris A, Sacktor TC. 1996. Protein synthesis-dependent formation of protein kinase Mζ in long-term potentiation. J. Neurosci. 16, 2444–2451 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Ling DS, Benardo LS, Serrano PA, Blace N, Kelly MT, Crary JF, Sacktor TC. 2002. Protein kinase Mζ is necessary and sufficient for LTP maintenance. Nat. Neurosci. 5, 295–296 (doi:10.1038/nn829) [DOI] [PubMed] [Google Scholar]
- 9.Pastalkova E, Serrano P, Pinkhasova D, Wallace E, Fenton AA, Sacktor TC. 2006. Storage of spatial information by the maintenance mechanism of LTP. Science 313, 1141–1144 (doi:10.1126/science.1128657) [DOI] [PubMed] [Google Scholar]
- 10.Shema R, Haramati S, Ron S, Hazvi S, Chen A, Sacktor TC, Dudai Y. 2011. Enhancement of consolidated long-term memory by overexpression of protein kinase Mzeta in the neocortex. Science 331, 1207–1210 (doi:10.1126/science.1200215) [DOI] [PubMed] [Google Scholar]
- 11.Kelly MT, Crary JF, Sacktor TC. 2007. Regulation of protein kinase Mζ synthesis by multiple kinases in long-term potentiation. J. Neurosci. 27, 3439–3444 (doi:10.1523/JNEUROSCI.5612-06.2007) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Westmark P, CJ W, Wang S, Levenson J, KJ OR, Burger C, Malter J. 2010. Pin1 and PKMζ sequentially control dendritic protein synthesis. Sci. Signal. 3, ra18 (doi:10.1126/scisignal.2000451) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Madronal N, Gruart A, Sacktor TC, Delgado-Garcia JM. 2010. PKMζ inhibition reverses learning-induced increases in hippocampal synaptic strength and memory during trace eyeblink conditioning. PLoS ONE 5, e10400 (doi:10.1371/journal.pone.0010400) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Serrano P, Yao Y, Sacktor TC. 2005. Persistent phosphorylation by protein kinase Mζ maintains late-phase long-term potentiation. J. Neurosci. 25, 1979–1984 (doi:10.1523/JNEUROSCI.5132-04.2005) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Shema R, Hazvi S, Sacktor TC, Dudai Y. 2009. Boundary conditions for the maintenance of memory by PKMζ in neocortex. Learn. Mem. 16, 122–128 (doi:10.1101/lm.1183309) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Shema R, Sacktor TC, Dudai Y. 2007. Rapid erasure of long-term memory associations in cortex by an inhibitor of PKMζ. Science 317, 951–953 (doi:10.1126/science.1144334) [DOI] [PubMed] [Google Scholar]
- 17.Sacco T, Sacchetti B. 2010. Role of secondary sensory cortices in emotional memory storage and retrieval in rats. Science 329, 649–656 (doi:10.1126/science.1183165) [DOI] [PubMed] [Google Scholar]
- 18.He YY, Xue YX, Wang JS, Fang Q, Liu JF, Xue LF, Lu L. 2011. PKMzeta maintains drug reward and aversion memory in the basolateral amygdala and extinction memory in the infralimbic cortex. Neuropsychopharmacology 36, 1972–1981 (doi:10.1038/npp.2011.63) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.von Kraus LM, Sacktor TC, Francis JT. 2010. Erasing sensorimotor memories via PKMzeta inhibition. PLoS ONE 5, e11125 (doi:10.1371/journal.pone.0011125) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Sacktor TC. 2012. Memory maintenance by PKMzeta—an evolutionary perspective. Mol. Brain 5, 31 (doi:10.1186/1756-6606-5-31) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Angeles-Duran S, Ramos-Languren LE, Escobar ML. 2012. PKMzeta inhibition prevents the metaplastic change induced by conditioned taste aversion on insular cortex long-term potentiation in vivo. Rev. Neurosci. 23, 473–480 (doi:10.1515/revneuro-2012-0048) [DOI] [PubMed] [Google Scholar]
- 22.Li Q, Rothkegel M, Xiao ZC, Abraham WC, Korte M, Sajikumar S. In press. Making synapses strong: metaplasticity prolongs associativity of long-term memory by switching synaptic tag mechanisms. Cereb. Cortex. (doi:10.1093/cercor/bhs315) [DOI] [PubMed] [Google Scholar]
- 23.Wang J, Meng F, Cottrell JE, Sacktor TC, Kass IS. 2012. Metabotropic actions of the volatile anaesthetic sevoflurane increase protein kinase M synthesis and induce immediate preconditioning protection of rat hippocampal slices. J. Physiol. 590, 4093–4107 (doi:10.1113/jphysiol.2012.233965) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Li XY, Ko HG, Chen T, Collingridge GL, Kaang BK, Zhuo M. 2011. Erasing injury-related cortical synaptic potentiation as a new treatment for chronic pain. J. Mol. Med. (Berl) 89, 847–855 (doi:10.1007/s00109-011-0768-9) [DOI] [PubMed] [Google Scholar]
- 25.Price TJ, Ghosh S. 2013. ZIPping to pain relief: the role (or not) of PKMzeta in chronic pain. Mol. Pain 9, 6 (doi:10.1186/1744-8069-9-6) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Cohen H, Kozlovsky N, Matar MA, Kaplan Z, Zohar J. 2010. Mapping the brain pathways of traumatic memory: inactivation of protein kinase M zeta in different brain regions disrupts traumatic memory processes and attenuates traumatic stress responses in rats. Eur. Neuropsychopharmacol. 20, 253–271 (doi:10.1016/j.euroneuro.2009.12.006) [DOI] [PubMed] [Google Scholar]
- 27.Crary JF, Shao CY, Mirra SS, Hernandez AI, Sacktor TC. 2006. Atypical protein kinase C in neurodegenerative disease I: PKMζ aggregates with limbic neurofibrillary tangles and AMPA receptors in Alzheimer disease. J. Neuropathol. Exp. Neurol. 65, 319–326 (doi:10.1097/01.jnen.0000218442.07664.04) [DOI] [PubMed] [Google Scholar]
- 28.Wouterlood FG, Jorritsma-Byham B. 1993. The anterograde neuroanatomical tracer biotinylated dextran-amine: comparison with the tracer Phaseolus vulgaris-leucoagglutinin in preparations for electron microscopy. J. Neurosci. Methods 48, 75–87 (doi:10.1016/S0165-0270(05)80009-3) [DOI] [PubMed] [Google Scholar]
- 29.Levy RB, Aoki C. 2002. Alpha7 nicotinic acetylcholine receptors occur at postsynaptic densities of AMPA receptor-positive and -negative excitatory synapses in rat sensory cortex. J. Neurosci. 22, 5001–5015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Reynolds ES. 1963. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J. Cell Biol. 17, 208–212 (doi:10.1083/jcb.17.1.208) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Bergersen LH, Magistretti PJ, Pellerin L. 2005. Selective postsynaptic co-localization of MCT2 with AMPA receptor GluR2/3 subunits at excitatory synapses exhibiting AMPA receptor trafficking. Cereb. Cortex 15, 361–370 (doi:10.1093/cercor/bhh138) [DOI] [PubMed] [Google Scholar]
- 32.Migues PV, Hardt O, Wu DC, Gamache K, Sacktor TC, Wang YT, Nader K. 2010. PKMζ maintains memories by regulating GluR2-dependent AMPA receptor trafficking. Nat. Neurosci. 13, 630–634 (doi:10.1038/nn.2531) [DOI] [PubMed] [Google Scholar]
- 33.Lee AM, et al. 2013. Prkcz null mice show normal learning and memory. Nature 493, 416–419 (doi:10.1038/nature11803) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Volk LJ, Bachman JL, Johnson R, Yu Y, Huganir RL. 2013. PKM-zeta is not required for hippocampal synaptic plasticity, learning and memory. Nature 493, 420–423 (doi:10.1038/nature11802) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Yao Y, Tsokas P, Jothianandan D, Tcherepanov A, van de Nes P, Sacktor TC. 2013. Compensation by PKCι/λ activation and PKMι/λ formation in PKMζ knock-out mice. Soc. Neurosci. Abstr. program# 233.22. http://www.abstractsonline.com/Plan/ViewAbstract.aspx?mID=3236&sKey=6bc2b62b-cc81-4ad4-9245-52909d0cf884&cKey=ff4334ac-acb0-4745-8559-d4fd41a58ed1&mKey=8d2a5bec-4825-4cd6-9439-b42bb151d1cf. [Google Scholar]
- 36.Ren SQ, Yan JZ, Zhang XY, Bu YF, Pan WW, Yao W, Tian T, Lu W. 2013. PKClambda is critical in AMPA receptor phosphorylation and synaptic incorporation during LTP. EMBO J. 32, 1365–1380 (doi:10.1038/emboj.2013.60) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Tsokas P, et al. 2013. Conditional knockout of the PKC/PKMζ gene and acute translational blockade by PKMζ antisense show new synthesis of PKMζ protein is crucial for LTP and long-term memory. Soc. Neurosci. Abstr. program# 233.21. http://www.abstractsonline.com/Plan/ViewAbstract.aspx?mID=3236&sKey=6bc2b62b-cc81-4ad4-9245-52909d0cf884&cKey=5e99dcac-b2ed-4087-9c15-475f6991c757&mKey=8d2a5bec-4825-4cd6-9439-b42bb151d1cf. [Google Scholar]
- 38.Hara Y, Punsoni M, Yuk F, Park CS, Janssen WG, Rapp PR, Morrison JH. 2012. Synaptic distributions of GluA2 and PKMzeta in the monkey dentate gyrus and their relationships with aging and memory. J. Neurosci. 32, 7336–7344 (doi:10.1523/JNEUROSCI.0605-12.2012) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Yao Y, Kelly MT, Sajikumar S, Serrano P, Tian D, Bergold PJ, Frey JU, Sacktor TC. 2008. PKMζ maintains late long-term potentiation by N-ethylmaleimide-sensitive factor/GluR2-dependent trafficking of postsynaptic AMPA receptors. J. Neurosci. 28, 7820–7827 (doi:10.1523/JNEUROSCI.0223-08.2008) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Ling DS, Benardo LS, Sacktor TC. 2006. Protein kinase Mζ enhances excitatory synaptic transmission by increasing the number of active postsynaptic AMPA receptors. Hippocampus 16, 443–452 (doi:10.1002/hipo.20171) [DOI] [PubMed] [Google Scholar]
- 41.Guan Z, Giustetto M, Lomvardas S, Kim JH, Miniaci MC, Schwartz JH, Thanos D, Kandel ER. 2002. Integration of long-term-memory-related synaptic plasticity involves bidirectional regulation of gene expression and chromatin structure. Cell 111, 483–493 (doi:10.1016/S0092-8674(02)01074-7) [DOI] [PubMed] [Google Scholar]
- 42.Hernandez AI, Wolk J, Hu JY, Liu J, Kurosu T, Schwartz JH, Schacher S. 2009. Poly-(ADP-ribose) polymerase-1 is necessary for long-term facilitation in Aplysia. J. Neurosci. 29, 9553–9562 (doi:10.1523/JNEUROSCI.1512-09.2009) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Cohen-Armon M, Visochek L, Katzoff A, Levitan D, Susswein AJ, Klein R, Valbrun M, Schwartz JH. 2004. Long-term memory requires polyADP-ribosylation. Science 304, 1820–1822 (doi:10.1126/science.1096775) [DOI] [PubMed] [Google Scholar]
- 44.Day JJ, Sweatt JD. 2011. Cognitive neuroepigenetics: a role for epigenetic mechanisms in learning and memory. Neurobiol. Learn. Mem. 96, 2–12 (doi:10.1016/j.nlm.2010.12.008) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Miller CA, et al. 2010. Cortical DNA methylation maintains remote memory. Nat. Neurosci. 13, 664–666 (doi:10.1038/nn.2560) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Zhou G, Seibenhener ML, Wooten MW. 1997. Nucleolin is a protein kinase C-ζ substrate. Connection between cell surface signaling and nucleus in PC12 cells. J. Biol. Chem. 272, 31 130–31 137 (doi:10.1074/jbc.272.49.31130) [DOI] [PubMed] [Google Scholar]
- 47.Wooten MW, Zhou G, Wooten MC, Seibenhener ML. 1997. Transport of protein kinase C isoforms to the nucleus of PC12 cells by nerve growth factor: association of atypical ζ-PKC with the nuclear matrix. J. Neurosci. Res. 49, 393–403 (doi:10.1002/(SICI)1097-4547(19970815)49:4<393::AID-JNR1>3.0.CO;2-3) [DOI] [PubMed] [Google Scholar]
- 48.Kind PC, Kelly GM, Fryer HJ, Blakemore C, Hockfield S. 1997. Phospholipase C-beta1 is present in the botrysome, an intermediate compartment-like organelle, and is regulated by visual experience in cat visual cortex. J. Neurosci. 17, 1471–1480 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Shinoda K, Nagano M, Osawa Y. 1993. An aromatase-associated cytoplasmic inclusion, the “stigmoid body,” in the rat brain: II. Ultrastructure (with a review of its history and nomenclature). J. Comp. Neurol. 329, 1–19 (doi:10.1002/cne.903290102) [DOI] [PubMed] [Google Scholar]
- 50.Takeuchi IK, Takeuchi YK. 1982. Ultrastructural and cytochemical studies on nucleolus-like bodies in early postimplantation rat embryos. Cell Tissue Res. 226, 257–266 (doi:10.1007/BF00218357) [DOI] [PubMed] [Google Scholar]
- 51.Hannan AJ, Kind PC, Blakemore C. 1998. Phospholipase C-beta1 expression correlates with neuronal differentiation and synaptic plasticity in rat somatosensory cortex. Neuropharmacology 37, 593–605 (doi:10.1016/S0028-3908(98)00056-2) [DOI] [PubMed] [Google Scholar]
- 52.Hannan AJ, et al. 2001. PLC-beta1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex. Nat. Neurosci. 4, 282–288 (doi:10.1038/85132) [DOI] [PubMed] [Google Scholar]
- 53.Li SH, Li H, Torre ER, Li XJ. 2000. Expression of huntingtin-associated protein-1 in neuronal cells implicates a role in neuritic growth. Mol. Cell. Neurosci. 16, 168–183 (doi:10.1006/mcne.2000.0858) [DOI] [PubMed] [Google Scholar]
- 54.Serrando M, Casanovas A, Esquerda JE. 2002. Occurrence of glutamate receptor subunit 1-containing aggresome-like structures during normal development of rat spinal cord interneurons. J. Comp. Neurol. 442, 23–34 (doi:10.1002/cne.1419) [DOI] [PubMed] [Google Scholar]




